REG3α has long been proposed as a biomarker of intestinal epithelial damage in multiple inflammatory diseases in which plasma REG3α levels are significantly elevated, such as CD, celiac disease, ulcerative colitis, nonalcoholic steatohepatitis, and gastrointestinal graft-versus-host disease (129–133). The gene discussed is REG3A; the disease is ulcerative colitis.